03:32 PM EST, 01/23/2025 (MT Newswires) -- Cedric Francois, Director, Chief Executive Officer, on January 22, 2025, sold 13,551 shares in Apellis Pharmaceuticals ( APLS ) for $412,296. Following the Form 4 filing with the SEC, Francois has control over a total of 1,957,941 shares of the company, with 418,519 shares held directly and 1,539,422 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000112760225001837/xslF345X05/form4.xml

Price: 31.04, Change: +0.65, Percent Change: +2.14